Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer

OncoImmunology

Volumn 4, Issue 4, 2015, Pages

  Jia, Qingzhu ^a,b,c   Zhou, Junfeng ^a   Chen, Gang ^b,c   Shi, Yan ^a   Yu, Haili ^b,c   Guan, Peng ^b,c   Lin, Regina ^d   Jiang, Ning ^e   Yu, Peiwu ^a   Li, Qi Jing ^c,d   Wan, Ying ^b,c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c Chongqing Key Laboratory of Neurology   (China)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e The University of Texas at Austin   (United States)

Author keywords

Gastric cancer; Mucosal residence; Prognosis; Repertoire sequencing; T cell repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MATHEMATICAL ANALYSIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CANCER; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION;

EID: 84954349102     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2014.1001230     Document Type: Article

References (51)

1. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14:113-23; PMID:21573742; http:dx/doi. org/ 10. 1007/s10120-011-0042-4
2. Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol 2014; 232:199-209; PMID:24122236; http://dx. doi. org/10. 1002/path. 4287
3. Halpern AC, Schuchter LM. Prognostic models in melanoma. Semin Oncol 1997; 24:S2-7; PMID:9122730
4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx. doi. org/10. 1126/science. 1129139
5. Whiteside TL. Immune responses to cancer: are they potential biomarkers of prognosis? Front Oncol 2013; 3:107; PMID:23730621; http://dx. doi. org/10. 3389/ fonc. 2013. 00107
6. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx. doi. org/10. 1038/nrc3245
7. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx. doi. org/10. 1016/j. cell. 2011. 02. 013
8. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx. doi. org/10. 1126/science. 1203486
9. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr., Kinzler KW. Cancer genome landscapes. Science (New York, NY) 2013; 339:1546-58; PMID:23539594
10. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Eng J Med 2005; 353:2654-66; PMID:16371631; http://dx. doi. org/10. 1056/NEJMoa051424
11. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-7; PMID:11264538; http://dx. doi. org/10. 1126/science. 1058867
12. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature immunology 2003; 4:225-34; PMID:12563257; http://dx. doi. org/10. 1038/ ni889
13. Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 2012; 483:227-31; PMID:22388819; http://dx. doi. org/10. 1038/nature10851
14. Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, Heath WR, Carbone FR, Gebhardt T. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A 2012; 109:7037-42; PMID:22509047; http://dx. doi. org/ 10. 1073/pnas. 1202288109
15. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol 2013; 14:1294-301; PMID:24162776; http://dx. doi. org/10. 1038/ni. 2744
16. Cauley LS, Lefrancois L. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. MucosalIimmunol 2013; 6:14-23; PMID:23131785; http://dx. doi. org/10. 1038/mi. 2012. 96
17. Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ. T cells as a self-referential, sensory organ. Annu RevImmunol 2007; 25:681-95; PMID:17291190; http://dx. doi. org/10. 1146/annurev. immunol. 24. 021605. 090600
18. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y. Ligand recognition by alpha beta T cell receptors. Ann Rev Immunol 1998; 16:523-44; PMID:9597140; http://dx. doi. org/10. 1146/annurev. immunol. 16. 1. 523
19. Ebert PJ, Li QJ, Huppa JB, Davis MM. Functional development of the T cell receptor for antigen. Prog Mol Biol Transl Sci 2010; 92:65-100; PMID:20800817; http://dx. doi. org/10. 1016/S1877-1173(10)92004-8.
20. Chien YH, Gascoigne NR, Kavaler J, Lee NE, Davis MM. Somatic recombination in a murine T-cell receptor gene. Nature 1984; 309:322-6; PMID:6328306; http://dx. doi. org/10. 1038/309322a0
21. Krangel MS. Mechanics of T cell receptor gene rearrangement. Curr Opin Immunol 2009; 21:133-9; PMID:19362456; http://dx. doi. org/10. 1016/j. coi. 2009. 03. 009
22. Schatz DG, Ji Y. Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 2011; 11:251-63; PMID:21394103; http://dx. doi. org/10. 1038/nri2941
23. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. An alphabeta T cell receptor structure at 2. 5 A and its orientation in the TCR-MHC complex. Science 1996; 274:209-19; PMID:8824178; http://dx. doi. org/ 10. 1126/science. 274. 5285. 209
24. Thor Straten P, Schrama D, Andersen MH, Becker JC. T-cell clonotypes in cancer. J Transl Med 2004; 2:11; PMID:15072580; http://dx. doi. org/10. 1186/1479-5876-2-11
25. Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathology 2013; 231:433-40; PMID:24027095; http://dx. doi. org/10. 1002/path. 4260
26. Klarenbeek PL, de Hair MJ, Doorenspleet ME, van Schaik BD, Esveldt RE, van de Sande MG, Cantaert T, Gerlag DM, Baeten D, van Kampen AH et al. Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann Rheum Dis 2012; 71:1088-93; PMID:22294635; http://dx. doi. org/10. 1136/ annrheumdis-2011-200612
27. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366:883-92; PMID:22397650; http://dx. doi. org/10. 1056/NEJMoa 1113205
28. Martinez P, Birkbak NJ, Gerlinger M, McGranahan N, Burrell RA, Rowan AJ, Joshi T, Fisher R, Larkin J, Szallasi Z et al. Parallel evolution of tumour subclones mimics diversity between tumours. J Pathol 2013; 230:356-64; PMID:23716380; http://dx. doi. org/ 10. 1002/path. 4214
29. Gerlinger M, Quezada SA, Peggs KS, Furness AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ, Hazell S et al. Ultra-deep T-cell receptor sequencing reveals the complexity and intratumour heterogeneity of T-cell clones in renal cell carcinomas. J Pathol 2013; 231:424-32, PMID:24122851
30. Serana F, Sottini A, Caimi L, Palermo B, Natali PG, Nistico P, Imberti L. Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients. J Transl Med 2009; 7:21; PMID:19317896; http://dx. doi. org/10. 1186/ 1479-5876-7-21
31. Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol, immunother 2013; 62:1453-61; PMID:23771160; http://dx. doi. org/10. 1007/s00262-013-1446-2
32. Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Ex Med 1994; 180:1159-64; PMID:8064232; http://dx. doi. org/10. 1084/jem. 180. 3. 1159
33. Olurinde MO, Shen CH, Drake A, Bai A, Chen J. Persistence of tumor-infiltrating CD8 T cells is tumordependent but antigen-independent. Cell Mol Immunol 2011; 8:415-23; PMID:21666707; http://dx. doi. org/10. 1038/cmi. 2011. 18
34. Grotz TE, Vaince F, Hieken TJ. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes. Melanoma Res 2013; 23:132-7; PMID:23344159; http://dx. doi. org/ 10. 1097/CMR. 0b013e32835e5880
35. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005; 102:18538-43. Epub 2005 Dec 12; PMID:16344461; http://dx. doi. org/10. 1073/pnas. 0509182102
36. Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, Laghi L, Allavena P, Mantovani A, Marchesi F. Occurrence of tertiary lymphoid tissue is associated to T cell infiltration and predicts better prognosis in early stage colorectal cancers. Clin Cancer Res 2014; 12:12; PMID:24523438; http://dx. doi. org/10. 1158/ 1078-0432. CCR-13-2590
37. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22:329-60; PMID:15032581; http://dx. doi. org/ 10. 1146/annurev. immunol. 22. 012703. 104803
38. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl Journal Med 2012; 366:2443-54; PMID:22658127; http:// dx. doi. org/10. 1056/NEJMoa1200690
39. Galon J, Pages F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA. The immune score as a new possible approach for the classification of cancer. J Transl Med 2012; 10:1; PMID:22214470; http://dx. doi. org/10. 1186/1479-5876-10-1
40. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9. Epub 2004 Aug 22; PMID:15322536; http://dx. doi. org/10. 1038/nm1093
41. Masopust D, Vezys V, Wherry EJ, Barber DL, Ahmed R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol (Baltimore, Md: 1950) 2006; 176:2079-83.
42. Ling KL, Dulphy N, Bahl P, Salio M, Maskell K, Piris J, Warren BF, George BD, Mortensen NJ, Cerundolo V. Modulation of CD103 expression on human colon carcinoma-specific CTL. J Immunol (Baltimore, Md: 1950) 2007; 178:2908-15.
43. Kilinc MO, Gu T, Harden JL, Virtuoso LP, Egilmez NK. Central role of tumor-associated CD8+ T effector/ memory cells in restoring systemic antitumor immunity. J Immunol (Baltimore, Md: 1950) 2009; 182:4217-25; PMID:19299720; http://dx. doi. org/ 10. 4049/jimmunol. 0802793
44. Webb JR, Milne K, Watson P, Deleeuw RJ, Nelson BH. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res 2014; 20:434-44; PMID:24190978; http://dx. doi. org/10. 1158/1078-0432. CCR-13-1877
45. Zhang N, Bevan MJ. Transforming growth factor-beta signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 2013; 39:687-96; PMID:24076049; http://dx. doi. org/10. 1016/j. immuni. 2013. 08. 019
46. Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdorffer E, Malfertheiner P. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br JCancer 2000; 82:1795-800; PMID:10839293; http://dx. doi. org/ 10. 1054/bjoc. 1999. 1107
47. Wakim LM, Woodward-Davis A, Bevan MJ. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A 2010; 107:17872-9; PMID:20923878; http://dx. doi. org/10. 1073/ pnas. 1010201107
48. Schenkel JM, Fraser KA, Vezys V, Masopust D. Sensing and alarm function of resident memory CD8(+) T cells. Nature Immunol 2013; 14:509-13; PMID:23542740; http://dx. doi. org/10. 1038/ni. 2568
49. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013; 497:258-62; Epub 2013 Apr 28; PMID:23624374; http://dx. doi. org/10. 1038/nature12079
50. Stewart JJ, Lee CY, Ibrahim S, Watts P, Shlomchik M, Weigert M, Litwin S. A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol 1997; 34:1067-82; PMID:9519765; http://dx. doi. org/ 10. 1016/S0161-5890(97)00130-2
51. Rempala GA, Seweryn M. Methods for diversity and overlap analysis in T-cell receptor populations. J of Math Biol 2013; 67:1339-68; PMID:23007599; http://dx. doi. org/10. 1007/s00285-012-0589-7